The 50 Insider
-
AstraZeneca investing up to $250m in AI design of antibody to fight cancer
Cambridge-based Big Biotech company AstraZeneca is reportedly investing around $250 million in an exciting move designed to fashion an antibody to... Read More
-
bit.bio collaborates with King’s College London in brain therapy advance
Cambridge-based bit.bio has announced a collaboration with the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College... Read More
-
NICE work as Endomag breast cancer tech wins key backing
Cambridge-based Endomag’s ground-breaking magnetic lymphatic tracer Magtrace® has received its recommendation from the National Institute for Health... Read More
-
Monumental success as TeraView’s imaging technology monitors Stonehenge
Work by Cambridge company TeraView to help unravel the mysteries of Stonehenge, the ancient burial ground in Wiltshire, is being showcased at a... Read More
-
Optibrium expands to new Cambridge HQ
Optibrium™, a developer of software for drug discovery, has expanded its UK headquarters with a move to larger office premises on Cambridge... Read More
-
ieso study proves value of integrated approaches for mental healthcare in diabetes
ieso, Cambridge’s data-driven AI healthcare company pioneering next-generation digital therapeutics in mental health, has unveiled study results... Read More
-
Darktrace CEO calls for ‘tech NATO’ to police cybercrime
The CEO of Killer50 superstar Darktrace says there is “a shocking tolerance” to cyber attacks and urges additional vigilance. Poppy Gustafsson... Read More
-
CMR Surgical opens Brazil office with Chile next in Latin America push
Surgery with a samba backbeat marks the latest exciting exploit for CMR Surgical in Cambridge. The pioneering MedTech company is planning major... Read More
-
1Spatial wins maiden New York deal
Cambridge-based location technology specialist 1Spatial has taken a first bite out of the Big Apple via a maiden contract with the State of New York... Read More
-
Alchemab identifies cancer and neurodegenerative disease drug targets
Cambridge-based biotech company Alchemab Therapeutics is enjoying widespread success with its trailblazing transformer neural network, AntiBERTa.... Read More
-
Evonetix granted European patent for novel gene assembly method
Cambridge synthetic biology company Evonetix has strengthened its IP portfolio by earning a European patent covering its Binary Assembly method for... Read More
-
STORM Therapeutics funded to fight coronavirus diseases
Cambridge University spin-out STORM Therapeutics has won an unspecified Biomedical Catalyst grant by Innovate UK to research and develop new drugs... Read More
-
French connection helps Cambridge Mechatronics in nextgen haptics play
Cambridge Mechatronics (CML), and French company Interhaptics have agreed a strategic collaboration to bring a cutting-edge AR/VR haptics technology... Read More
-
Evonetix DNA IP boosted by European patent
Evonetix, a Cambridge-based synthetic biology company, has won a significant patent approval in Europe. It covers the company’s proprietary thermal... Read More
-
GW parent company creates 100 jobs with new facility
The marriage of Cambridge biotechnology with Irish nous and cash – allied to US visibility – are all evidenced in a major UK expansion for Nasdaq-... Read More
-
Arecor wins key US patent milestone for diabetes products
Cambridge’s Arecor Therapeutics plc has won a key patent approval in the US as it turns its IP portfolio into a veritable pharma fortress. The... Read More
-
Alchemab and Medicines Discovery Catapult pioneer fresh advances
Cambridge biotech Alchemab Therapeutics has extended a collaboration with Medicines Discovery Catapult (MDC) – a national facility enabling the UK’s... Read More
-
Montana joins queue for 1Spatial software
Montana has become the seventh American State and the eighth US customer overall to take locational technology from quoted Cambridge company 1Spatial... Read More
-
CMR Surgical wins key Versius deal in Italy
CMR Surgical’s Versius robotic system is being used in an Italian public hospital for the first time.The development gives the Cambridge company a... Read More
-
Bango strikes oil with Texas alliance
A Cambridge-Texas collaboration is set to enhance secure payment options for app developers’ end users. Bango plc has joined forces with NASDAQ-... Read More